Nanomaterial strategies for antibiotic-resistant infections: Mechanistic frameworks, rational design, and clinical translation
Abstract
Antimicrobial resistance drives substantial global morbidity and mortality, yet conventional antibiotics often fail in rapidly disseminating planktonic bloodstream infections or sepsis, intracellular reservoirs with limited drug exposure, and biofilm- or device-associated infections that are prone to relapse. Nanomaterials provide an interface-focused, multitarget approach that combines direct antibacterial activity, controlled delivery, and host modulation. Here, we evaluate antibacterial nanomaterials according to the major biological barriers encountered during the infection cascade, including surface precolonization, adhesion and invasion, biofilm maturation, intracellular persistence, and tissue spread or relapse. These barriers correspond to material functions such as membrane permeabilization, proton-motive-force and efflux modulation, matrix penetration and remodeling, intracellular release, and host-directed immunomodulation. Current strategies broadly include intrinsically antibacterial materials and nanocarriers that enhance the activity of existing antibiotics through controlled release or externally triggered activation. Evidence is evaluated through quantitative readouts linking mechanisms to outcomes, including bacterial burden reduction, biofilm remodeling, intracellular clearance, and relapse-related endpoints. We also discuss diagnostic and image-guided systems, together with translational requirements such as reproducible manufacturing, controlled ion or…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.